-
1.发明授权公开(公告)号：US10005771B2
公开(公告)日：2018-06-26
申请号：US15514294
申请日：2015-09-25
Applicant: Almirall, S.A.
Inventor： Carlos Puig Duran , Jose Aiguade Bosch , Silvia Gual Roig , Maria Prat Quiñones
IPC: C07D453/02 , A61K31/439
CPC classification number: C07D453/02 , C07D401/12
Abstract: The present invention relates to novel compounds having β2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
-
2.发明授权公开(公告)号：US09643961B2
公开(公告)日：2017-05-09
申请号：US15068926
申请日：2016-03-14
Applicant: Almirall, S.A.
Inventor： Maria Prat Quinones , Silvia Fonquerna Pou , Carlos Puig Duran , Wenceslao Lumeras Amador , Jose Aiguade Bosch , Juan Francisco Caturla Javaloyes
IPC: C07D215/26 , C07D409/14 , A61K31/4709 , C07D405/12 , C07D409/12 , C07D413/14
CPC classification number: C07D409/14 , A61K31/4709 , C07D215/26 , C07D405/12 , C07D409/12 , C07D413/14
Abstract: The present invention relates to novel compounds having β2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
-
3.发明申请公开(公告)号：US20180015097A1
公开(公告)日：2018-01-18
申请号：US15668817
申请日：2017-08-04
Applicant: ALMIRALL,S.A
Inventor： Jose AIGUADE BOSCH , Silvia Gual Roig , Maria Prat Quinones , Carlos Puig Duran
IPC: A61K31/538 , A61K31/4178 , C07D413/14 , C07D413/12 , C07D409/14 , C07D409/12 , C07D403/12 , C07D401/12 , C07D263/58 , A61K45/06 , A61K31/4709 , A61K31/428 , A61K31/423 , A61K31/4184 , C07D417/12 , C07D417/14
CPC classification number: A61K31/538 , A61K31/4178 , A61K31/4184 , A61K31/423 , A61K31/428 , A61K31/4709 , A61K45/06 , C07D263/58 , C07D401/12 , C07D403/12 , C07D409/12 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14
Abstract: The present invention relates to novel compounds having β2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
-
4.发明授权公开(公告)号：US10300072B2
公开(公告)日：2019-05-28
申请号：US15668817
申请日：2017-08-04
Applicant: ALMIRALL, S.A.
Inventor： Jose Aiguade Bosch , Silvia Gual Roig , Maria Prat Quinones , Carlos Puig Duran
IPC: C07D403/12 , A61K31/538 , C07D413/14 , C07D409/12 , C07D409/14 , C07D417/14 , A61K31/4178 , A61K31/423 , A61K31/428 , A61K31/4709 , A61K45/06 , C07D263/58 , C07D401/12 , C07D413/12 , C07D417/12 , A61K31/4184
Abstract: The present invention relates to novel compounds having β2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
-
5.发明授权Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities 有权具有β2肾上腺素能激动剂和M3毒蕈碱拮抗剂活性的环己胺衍生物公开(公告)号：US09549934B2
公开(公告)日：2017-01-24
申请号：US14956836
申请日：2015-12-02
Applicant: ALMIRALL, S.A.
Inventor： Jose Aiguade Bosch , Silvia Gual Roig , Maria Prat Quinones , Carlos Puig Duran
IPC: A61K31/58 , A61K31/538 , C07D403/12 , C07D413/14 , C07D409/12 , C07D409/14 , C07D417/14 , A61K31/4178 , A61K31/423 , A61K31/428 , A61K31/4709 , A61K45/06 , C07D263/58 , C07D401/12 , C07D413/12 , C07D417/12 , A61K31/4184
CPC classification number: A61K31/538 , A61K31/4178 , A61K31/4184 , A61K31/423 , A61K31/428 , A61K31/4709 , A61K45/06 , C07D263/58 , C07D401/12 , C07D403/12 , C07D409/12 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14
Abstract: The present invention relates to novel compounds having β2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
Abstract translation: 本发明涉及具有β2肾上腺素能激动剂和M3毒蕈碱拮抗剂双重活性的新化合物，含有它们的药物组合物，其制备方法及其在呼吸治疗中的用途。
-
Patent Agency Ranking
6.发明授权Cyclohexyl and quinuclidinyl carbamate derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activity 有权具有β2肾上腺素能激动剂和M3毒蕈碱拮抗剂活性的环己基和奎宁环基氨基甲酸酯衍生物公开(公告)号：US09518050B2
公开(公告)日：2016-12-13
申请号：US14653048
申请日：2013-12-17
Applicant: ALMIRALL, S.A.
Inventor： Laia Sole Feu , Ines Carranco Moruno , Jose Aiguade Bosch , Carlos Puig Duran , Silvia Fonquerna Pou
IPC: C07D453/04 , A61K31/4709 , A61K31/475 , A61K31/4704 , C07D413/12 , A61K45/06 , A61K47/48 , A61K31/13 , A61K31/4184 , A61K31/439 , C07C271/38 , C07D453/02 , C07D213/75 , C07D215/26 , C07D401/12 , C07D249/18
CPC classification number: C07D453/04 , A61K31/13 , A61K31/4184 , A61K31/439 , A61K31/4704 , A61K31/4709 , A61K31/475 , A61K45/06 , A61K47/55 , C07C271/38 , C07C2601/14 , C07D213/75 , C07D215/26 , C07D249/18 , C07D401/12 , C07D413/12 , C07D453/02
Abstract: The present invention relates to novel compounds having β2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
Abstract translation: 本发明涉及具有β2肾上腺素能激动剂和M3毒蕈碱拮抗剂双重活性的新化合物，含有它们的药物组合物，其制备方法及其在呼吸治疗中的用途。
-
7.发明申请NEW CYCLOHEXYLAMINE DERIVATIVES HAVING BETA 2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES 审中-公开具有BETA 2 ADRENERGIC AGONIST和M3 MUSCARINIC ANTAGONIST活动的新CYCLOHEXYLAMINE衍生物公开(公告)号：US20140303127A1
公开(公告)日：2014-10-09
申请号：US14357400
申请日：2012-11-09
Applicant: ALMIRALL, S.A.
Inventor： Jose Aiguade Bosch , Silvia Gual Roig , Maria Prat Quinones , Carlos Puig Duran
IPC: C07D409/14 , A61K45/06 , C07D409/12 , A61K31/428 , C07D413/14 , A61K31/5377 , C07D417/14 , A61K31/4709 , A61K31/4184
CPC classification number: A61K31/4184 , A61K31/428 , A61K31/4709 , A61K31/5377 , A61K45/06 , C07D403/12 , C07D409/12 , C07D409/14 , C07D413/14 , C07D417/14
Abstract: The present invention relates to novel compounds having β2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
Abstract translation: 本发明涉及具有β-肾上腺素能激动剂和M3毒蕈碱拮抗剂双重活性的新化合物，含有它们的药物组合物，其制备方法及其在呼吸治疗中的用途。
-
8.发明授权Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both muscarinic receptor antagonist and β2 adrenergic receptor agonist activities 有权具有毒蕈碱受体拮抗剂和β2肾上腺素能受体激动剂活性的2-氨基-1-羟乙基-8-羟基喹啉-2（1H） - 酮衍生物的盐公开(公告)号：US09579316B2
公开(公告)日：2017-02-28
申请号：US14906991
申请日：2014-07-24
Applicant: Almirall, S.A.
Inventor： Montserrat Julia Jane , Francesc Carrera Carrera , Maria Prat Quiñones , Carlos Puig Duran , Francesca Pajuelo Lorenzo , Juan Antonio Perez Andres
IPC: A61K31/4709 , A61K45/06 , A61K9/00 , A61K31/4725 , C07D409/14 , C07D275/06 , C07C57/15 , C07D417/14
CPC classification number: A61K31/4709 , A61K9/0075 , A61K9/008 , A61K31/4725 , A61K45/06 , C07B2200/13 , C07C57/15 , C07D275/06 , C07D409/14 , C07D417/14 , A61K2300/00
Abstract: The present invention is directed to crystalline addition salts of (i) 8-hydroxyquinolin-2(1H)-one derivatives and (ii) a dicarboxylic acid or a sulfimide, or a pharmaceutically acceptable solvates thereof.
Abstract translation: 本发明涉及（i）8-羟基喹啉-2（1H） - 酮衍生物和（ii）二羧酸或硫酰亚胺或其药学上可接受的溶剂合物的结晶加成盐。
-
9.发明授权Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both β2 adrenergic receptor agonist and M3 muscarinic receptor antagonist activities 有权具有β2肾上腺素能受体激动剂和M3毒蕈碱受体拮抗剂活性的2-氨基-1-羟乙基-8-羟基喹啉-2（1H） - 酮衍生物的盐公开(公告)号：US09562039B2
公开(公告)日：2017-02-07
申请号：US14770206
申请日：2014-02-27
Applicant: ALMIRALL, S.A.
Inventor： Montserrat Julia Jane , Francesc Carrera Carrera , Maria Prat Quiñones , Carlos Puig Duran , Francesca Pajuelo Lorenzo , Juan Antonio Perez Andres
IPC: C07D409/14 , A61K31/4709 , A61K45/06 , A61K9/00 , C07C59/255 , C07C309/05 , C07D275/06
CPC classification number: C07D409/14 , A61K9/0073 , A61K9/0075 , A61K31/4709 , A61K45/06 , C07B2200/13 , C07C59/255 , C07C309/05 , C07D275/06 , A61K2300/00
Abstract: The present invention is directed to crystalline addition salts of (i) 8-hydroxyquinolin-2(1H)-one derivatives and (ii) a hydroxycarboxylic acid, a sulfonic acid or a sulfimide, or a pharmaceutically acceptable solvates thereof.
Abstract translation: 本发明涉及（i）8-羟基喹啉-2（1H） - 酮衍生物和（ii）羟基羧酸，磺酸或硫酰亚胺或其药学上可接受的溶剂合物的结晶加成盐。
-
10.发明申请NEW CYCLOHEXYLAMINE DERIVATIVES HAVING beta2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES 有权具有β2ADRENERGIC AGONIST和M3 MUSCARINIC ANTAGONIST活动的新CYCLOHEXYLAMINE衍生物公开(公告)号：US20140378421A1
公开(公告)日：2014-12-25
申请号：US14357344
申请日：2012-11-09
Applicant: ALMIRALL, S.A.
Inventor： Jose Aiguade Bosch , Silvia Gual Roig , Maria Prat Quinones , Carlos Puig Duran
IPC: A61K31/4709 , A61K45/06 , C07D401/12 , C07D409/12 , C07D413/14 , A61K31/428 , A61K31/4178 , C07D263/58 , A61K31/423 , A61K31/538 , C07D417/14 , C07D413/12 , C07D417/12
CPC classification number: A61K31/538 , A61K31/4178 , A61K31/4184 , A61K31/423 , A61K31/428 , A61K31/4709 , A61K45/06 , C07D263/58 , C07D401/12 , C07D403/12 , C07D409/12 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14
Abstract: The present invention relates to novel compounds having β2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
Abstract translation: 本发明涉及具有β-肾上腺素能激动剂和M3毒蕈碱拮抗剂双重活性的新化合物，含有它们的药物组合物，其制备方法及其在呼吸治疗中的用途。
-
-
-
-
-
-
-
-
-
Search Results
15
records
(took 0.031 seconds)
